Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log

June 13, 2024

Reassessed

• AI-10-49 (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Bezitramide (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Brorphine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Elafibranor (talk) reassessed. Importance rating changed from Unknown-Class to Mid-Class. (rev · t)

Assessed

• Brepocitinib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• CHZ868 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Draft:Centrient Pharmaceuticals (talk) assessed. Importance assessed as NA-Class. (rev · t)
• Emavusertib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Gusacitinib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Izencitinib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Lolamicin (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Draft:Peixuan Guo (talk) assessed. Importance assessed as NA-Class. (rev · t)
• Ropsacitinib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Seidlitz powders (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Category:Species endangered by human consumption for medicinal or magical purposes (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• Zimlovisertib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

June 12, 2024

Assessed

• VVD-118313 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Z583 (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Zasocitinib (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)

June 11, 2024

Reassessed

• 2-Benzylpiperidine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• 3-(p-Fluorobenzoyloxy)tropane (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Amfonelic acid (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Bemegride (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Bradanicline (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Brasofensine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Brown-brown (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Difluoropine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Dimethyl phthalate (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Methyl aminolevulinate (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Salicylmethylecgonine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Sibrafiban (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
• Tesofensine (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Tropatepine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Tropifexor (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Tropine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Wellcome Research Laboratories (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)

June 10, 2024

Assessed

• Sibrafiban (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
• Wellcome Research Laboratories (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)

June 9, 2024

Assessed

• Category:American pharmacists by populated place (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
• Category:American pharmacists by state (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)

June 8, 2024

Reassessed

• 2′-Acetoxycocaine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• 4-Hexylresorcinol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Amylocaine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Atazanavir/cobicistat (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Azoximer bromide (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Bambermycin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Belinostat (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Calcium dobesilate (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Imetelstat (talk) reassessed. Importance rating changed from Low-Class to Mid-Class. (rev · t)

June 7, 2024

Reassessed

• Antimotility agent (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Avacopan (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Belzutifan (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Bithionol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Caplacizumab (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Cenegermin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Concizumab (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Copper (64Cu) oxodotreotide (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Fabomotizole (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Fenticonazole (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Givosiran (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Indacaterol/glycopyrronium bromide/mometasone (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Inebilizumab (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Istradefylline (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Loncastuximab tesirine (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Luspatercept (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Macimorelin (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Maralixibat chloride (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Mirvetuximab soravtansine (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Mobocertinib (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Mogamulizumab (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Monobactam (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Mosunetuzumab (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Nedosiran (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Odevixibat (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Probucol (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Tofersen (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Tralokinumab (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
• Trilaciclib (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
• Velmanase alfa (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)

Assessed

• KL-50 (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
• Draft:Shao Li (talk) assessed. Importance assessed as NA-Class. (rev · t)
• Draft:Terry Pirovolakis (talk) assessed. Importance assessed as NA-Class. (rev · t)